Chronic hepatitis B
Do you want to receive a message when there is new research about Chronic hepatitis B? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence that explains what was investigated — and you receive a message as soon as there is new research about Chronic hepatitis B. View what Premium costs.
Publications and studies (2004)
- Cutoff Values of Acoustic Radiation Force Impulse Two-Location Measurements in Different Etiologies of Liver Fibrosis. (2019/05/17) ♡
- Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors. (2019/05/10) ♡
- VDR rs7975232/ApaI genetic variation predicts sustained HBsAg loss in HBeAg-positive chronic hepatitis B patients treated with pegylated interferon. (2019/05/01) ♡
- Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma. (2019/05/01) ♡
- Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. (2019/05/01) ♡
- The efficacy of Chinese patent medicine combined with entecavir for the treatment of chronic HBV-related liver fibrosis or cirrhosis: Protocol for a systematic review and meta-analysis of randomized controlled trials or prospective cohort studies. (2019/05/01) ♡
- Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. (2019/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [The faces of migrant health in France]. (2019/05/01) ♡
- Comprehensive Analysis of the mRNA-lncRNA Co-expression Profile and ceRNA Networks Patterns in Chronic Hepatitis B. (2019/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report. (2019/04/20) ♡
- Impact of malaria and hepatitis B co-infection on clinical and cytokine profiles among pregnant women. (2019/04/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules. (2019/04/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible? (2019/04/10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. (2019/04/06) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B. (2019/04/03) ♡
- Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. (2019/04/01) ♡
- Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase. (2019/04/01) ♡
- Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation. (2019/04/01) ♡
- A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion. (2019/04/01) ♡
- Effect of Fufang Biejia Ruangan Tablet on lowering biochemical and virological parameters of hepatic fibrosis in patients with chronic hepatitis B: Protocol for a systematic review and meta-analysis of randomized controlled trials and cohort studies. (2019/04/01) ♡
- Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. (2019/04/01) ♡
- The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection. (2019/04/01) ♡
- Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patients. (2019/04/01) ♡
- Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1/Ac-p53 regulatory axis. (2019/04/01) ♡
- AFP specificity for HCC surveillance is increased by mitigating liver injury among treated chronic hepatitis B patients with elevated AFP. (2019/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Booster immunity - diagnosis of chronic hepatitis B viral infection. (2019/03/31) ♡
- Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load. (2019/03/19) ♡
- Molecular mechanisms of tetrahydropyrrolo[1,2-c]pyrimidines as HBV capsid assembly inhibitors. (2019/03/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency. (2019/03/15) ♡
- Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study. (2019/03/10) ♡
- Effect of WSP, a Chinese Herbal Formula, on Th17/Treg Ratio and HBeAg Seroconversion in Telbivudine-Treated HBeAg-Positive Chronic Hepatitis B Patients with High Baseline ALT Levels (20-30 Times the ULN). (2019/03/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. HCMV jogs the 'memory' of NK cells in HBV. (2019/03/01) ♡
- HBV infection suppresses the expression of inflammatory macrophage miR‑210. (2019/03/01) ♡
- Interleukin-6 promotor gene polymorphisms and susceptibility to chronic hepatitis B virus in Egyptians. (2019/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on. (2019/03/01) ♡
- Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. (2019/03/01) ♡
- Immunotolerant Chronic Hepatitis B Infection: When Do I Treat? (2019/03/01) ♡
- Toll-like receptor 9 polymorphisms and Hepatitis B virus clearance in Moroccan chronic carriers. (2019/03/01) ♡
- Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. (2019/02/27) ♡
- 5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors. (2019/02/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Extracts of Qizhu decoction inhibit hepatitis and hepatocellular carcinoma in vitro and in C57BL/6 mice by suppressing NF-κB signaling. (2019/02/05) ♡
- De Novo Malignancies After Liver Transplantation: A Single Institution Experience. (2019/02/01) ♡
- Misclassification of chronic hepatitis B natural history phase: Insight from new ALT, AST, AKP, and GGT reference intervals in Chinese children. (2019/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus. (2019/02/01) ♡
- Different types of viral-host junction found in HBV integration breakpoints in HBV-infected patients. (2019/02/01) ♡
- Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway. (2019/02/01) ♡
- Hepatitis B Virus Inhibits Neutrophil Extracellular Trap Release by Modulating Reactive Oxygen Species Production and Autophagy. (2019/02/01) ♡
- Association of CCL11, CCL24 and CCL26 with primary biliary cholangitis. (2019/02/01) ♡
- A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma. (2019/02/01) ♡
- Efficacy of tenofovir disoproxil fumarate switch therapy in chronic hepatitis B patients with suboptimal response to adefovir-based combination therapy. (2019/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.